310 related articles for article (PubMed ID: 32526980)
1. The Role of ERα36 in Development and Tumor Malignancy.
Thiebaut C; Konan HP; Guerquin MJ; Chesnel A; Livera G; Le Romancer M; Dumond H
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526980
[TBL] [Abstract][Full Text] [Related]
2. From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression.
Chamard-Jovenin C; Jung AC; Chesnel A; Abecassis J; Flament S; Ledrappier S; Macabre C; Boukhobza T; Dumond H
BMC Syst Biol; 2015 Jun; 9():28. PubMed ID: 26080803
[TBL] [Abstract][Full Text] [Related]
3. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.
Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3τ drives estrogen receptor loss via ERα36 induction and GATA3 inhibition in breast cancer.
Garan LAW; Xiao Y; Lin WC
Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2209211119. PubMed ID: 36252018
[TBL] [Abstract][Full Text] [Related]
5. Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression.
Thiebaut C; Chamard-Jovenin C; Chesnel A; Morel C; Djermoune EH; Boukhobza T; Dumond H
PLoS One; 2017; 12(3):e0173931. PubMed ID: 28301550
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer.
Maczis MA; Maceyka M; Waters MR; Newton J; Singh M; Rigsby MF; Turner TH; Alzubi MA; Harrell JC; Milstien S; Spiegel S
J Lipid Res; 2018 Dec; 59(12):2297-2307. PubMed ID: 30315000
[TBL] [Abstract][Full Text] [Related]
7. Expression and localization of estrogen receptor in human breast cancer and its clinical significance.
Li L; Wang Q; Lv X; Sha L; Qin H; Wang L; Li L
Cell Biochem Biophys; 2015 Jan; 71(1):63-8. PubMed ID: 25113640
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of ERα66 and its novel variant isoform ERα36 in lactotroph pituitary adenomas and associations with clinicopathological characteristics.
Mahboobifard F; Bidari-Zerehpoosh F; Davoudi Z; Panahi M; Dargahi L; Pourgholami MH; Sharifi G; Izadi N; Jorjani M
Pituitary; 2020 Jun; 23(3):232-245. PubMed ID: 32026205
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen enhances stemness and promotes metastasis of ERα36
Wang Q; Jiang J; Ying G; Xie XQ; Zhang X; Xu W; Zhang X; Song E; Bu H; Ping YF; Yao XH; Wang B; Xu S; Yan ZX; Tai Y; Hu B; Qi X; Wang YX; He ZC; Wang Y; Wang JM; Cui YH; Chen F; Meng K; Wang Z; Bian XW
Cell Res; 2018 Mar; 28(3):336-358. PubMed ID: 29393296
[TBL] [Abstract][Full Text] [Related]
10. An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism.
Ajj H; Chesnel A; Pinel S; Plenat F; Flament S; Dumond H
PLoS One; 2013; 8(4):e61758. PubMed ID: 23626723
[TBL] [Abstract][Full Text] [Related]
11. Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer Cells.
Thiebaut C; Chesnel A; Merlin JL; Chesnel M; Leroux A; Harlé A; Dumond H
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146345
[TBL] [Abstract][Full Text] [Related]
12. The role of ERα36 in cell type-specific functions of estrogen and cancer development.
Mahboobifard F; Dargahi L; Jorjani M; Ramezani Tehrani F; Pourgholami MH
Pharmacol Res; 2021 Jan; 163():105307. PubMed ID: 33246174
[TBL] [Abstract][Full Text] [Related]
13. A Role for Estrogen Receptor alpha36 in Cancer Progression.
Pagano MT; Ortona E; Dupuis ML
Front Endocrinol (Lausanne); 2020; 11():506. PubMed ID: 32849292
[TBL] [Abstract][Full Text] [Related]
14. ERα36--Another piece of the estrogen puzzle.
Sołtysik K; Czekaj P
Eur J Cell Biol; 2015 Dec; 94(12):611-25. PubMed ID: 26522827
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Biological Significance of
Nagel A; Szade J; Iliszko M; Elzanowska J; Welnicka-Jaskiewicz M; Skokowski J; Stasilojc G; Bigda J; Sadej R; Zaczek A; Markiewicz A
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995757
[TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor α variants and c-Fos in rat mammary gland and tumors.
Gutiérrez A; Sambuco L; Álvarez L; Núñez M; Bergoc R; Zotta E; Martín G; Randi A
J Steroid Biochem Mol Biol; 2020 May; 199():105594. PubMed ID: 31968225
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance.
Song T; Zhang H; Zhao Q; Hu Z; Wang Z; Song Y; Zhang Z
Breast Cancer Res; 2024 Feb; 26(1):33. PubMed ID: 38409088
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into tumor-specific chaperoning activity of gamma synuclein in protecting estrogen receptor alpha 36 and its role in tamoxifen resistance in breast cancer.
Panneerselvam M; Muthu K; Ramadas K
Mol Biosyst; 2015 Nov; 11(11):2998-3010. PubMed ID: 26299756
[TBL] [Abstract][Full Text] [Related]
19. ERα36, a new variant of the ERα is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines.
Pelekanou V; Notas G; Kampa M; Tsentelierou E; Radojicic J; Leclercq G; Castanas E; Stathopoulos EN
Steroids; 2012 Aug; 77(10):928-34. PubMed ID: 22198466
[TBL] [Abstract][Full Text] [Related]
20. The Relative Expression of ERα Isoforms ERα66 and ERα36 Controls the Cellular Response to 24R,25-Dihydroxyvitamin D3 in Breast Cancer.
Verma A; Cohen DJ; Jacobs TW; Boyan BD; Schwartz Z
Mol Cancer Res; 2021 Jan; 19(1):99-111. PubMed ID: 33082240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
